Solésence Launches WHSPR™ & Chromalüm™ for Skin Health & SPF Cosmetics
Solésence, Inc. announced the commercial availability of two new proprietary platform technologies, WHSPR™ and Chromalüm™, significantly expanding its ingredient technology portfolio. WHSPR™ enables OTC-grade sensitive skin claims in previously inaccessible anhydrous formats, with clinical studies showing significant improvements in skin barrier recovery, hydration, and redness reduction. Chromalüm™ integrates broad-spectrum sun protection, including targeted high-energy visible (HEV) light protection, into color cosmetics without compromising aesthetic performance. These innovations reinforce Solésence's vertically integrated model, allowing brand partners to access differentiated product claims and expand category reach.
Key Highlights
- Solésence launched two new proprietary platform technologies: WHSPR™ and Chromalüm™.
- WHSPR™ enables OTC skin protectant claims in anhydrous formats for sensitive skin.
- WHSPR™ demonstrated up to 63% reduction in redness and 36% improvement in skin barrier recovery.
- WHSPR™ showed immediate hydration improvements of up to 112% above baseline.
- Chromalüm™ integrates broad-spectrum SPF and HEV light protection into color cosmetics.
- Both technologies are available through finished goods for global brand partners.
Price Impact
More from SLSN